Back to News
Market Impact: 0.2
Harnessing a Virus to Fight Brain Cancer: $2.5 Million NIH Award Advances Experimental Glioblastoma Therapy
Source: PR Newswire
Healthcare & BiotechTechnology & Innovation
An experimental Zika virus-based therapy for glioblastoma at Rosalind Franklin University's Helix 51 biomedical incubator is moving closer to potential human clinical trials. The article excerpt provides no trial timing, efficacy or safety data, or financial details.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.20
More News
- BlackRock, GIC among investors chasing Indian telecom major Jio's IPO as anchor bids top $26 billion
- Nscale, Anthropic Eye $45 Billion Cloud Deal as AI Trade Rebounds
- Gartner analyst behind tech rout: AI returns are not yet large enough to justify neocloud build-out
- Alibaba Backs Chinese Robovan Maker in $400 Million Fundraising
- X-Energy CEO on Amazon, AEP Nuclear Data Center Deal
- Ukraine’s drones lose their Starlink link above 100 mph. Musk, Rubio and Trump all say it wasn’t them
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- Selecting an AI Research Platform for Institutional Investors
- Weekly Update: New Reporting Features and More Sources for Document Search